Researchers in Singapore have conducted a study showing that the messenger RNA- (mRNA) based coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna are highly effective at protecting against symptomatic and severe disease following infection with the rapidly spreading B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The team conducted a multi-center retrospective cohort study of vaccinated and unvaccinated individuals who had been admitted to hospital following infection with the B.1.617.2 variant of concern.
“To our knowledge, we provide the first data characterizing the impact of vaccination on virologic kinetics by the B.1.617.2 variant,” writes Barnaby Young from the National Centre for Infectious Diseases in Singapore and colleagues.
The team found that individuals fully vaccinated with either Pfizer-BioNTech’s BNT162b2 vaccine or Moderna’s mRNA-1273 product were significantly less likely to develop moderate or severe outcomes following B.1.617.2 infection than unvaccinated individuals.
Vaccination was associated with fewer symptoms, lower peak biomarkers of systemic inflammation, and better clinical outcomes. It was also associated with a more rapid decline in viral RNA load and a robust serologic response.
“Vaccination remains a key strategy for control of COVID-19 pandemic,” says Young and colleagues.
A pre-print version of the research paper isa available on the medRxiv* server, while the article undergoes peer review.
.jpg "Study: Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study. Image Credit: NIAID")
Variants of concern pose a threat to vaccination efforts
Phase 3 clinical trials of mRNA-based vaccines have demonstrated efficacies of 92% to 95% in preventing symptomatic and severe disease following SARS-CoV-2 infection.
While the mass rollout of these vaccines has reduced infection and mortality rates in many countries, the emergence of SARS-CoV-2 variants containing mutations in the viral spike protein has led to growing concerns regarding increased transmissibility and resistance to vaccine-induced immunity.
The spike protein is the main structure the virus uses to infect cells and a primary target of binding and neutralizing antibodies following natural infection or vaccination.
While variants of concern such as B.1.1.7 (alpha), B.1.351 (beta), P.1 (gamma), and B.1.617.2 (delta) have all been shown to exhibit increased transmissibility, the B.1.1.7 and B.1.617.2 strains have also been associated with increased disease severity and hospitalization.
Following the emergence of B.1.617.2 in India, this variant rapidly spread to other countries and had become the most frequently sequenced lineage worldwide by the end of June 2021.
The vaccination program in Singapore
The COVID-19 vaccination program began in Singapore on December 30th, 2020. Free vaccination with either the Pfizer-BioNTech or Moderna product was made available to all Singapore residents, beginning with the elderly and those with high-risk occupations such as healthcare workers.
As of July 19th, 2021, more than 6,837,000 vaccine doses had been administered and approximately 2,792,400 individuals had been fully vaccinated.
What did the researchers do?
Young and colleagues conducted a multi-center retrospective cohort study to characterize the clinical, virologic and serologic features of vaccinated adults with breakthrough B.1.617.2 infection. The results were compared with those of unvaccinated patients who also had B.1.617.2 infection.
Participants were recruited between April 1st and June 14th, 2021, across five study sites: the National Centre for Infectious Diseases, Singapore General Hospital, National University Hospital, Changi General Hospital and Sengkang Hospital.
News
Where do nanoparticles go once they enter the body?
New international best practice guidance, co-written at ANSTO, sets out how to measure where nanoparticles like titanium dioxide end up in the body and how long they remain. The guidance has been shared by [...]
Long-Acting HIV Shots Could Solve a Major Treatment Challenge for Young People
A major African trial suggests that changing how HIV treatment is delivered could significantly improve viral suppression in adolescents. Young people with HIV were more likely to keep the virus suppressed when they received [...]
WHO Factsheets – The top 10 causes of death
In 2023, the 10 leading causes of death accounted for 33 million deaths, or 54% of the total 61 million deaths worldwide. The top global causes of death, in order of total number of lives lost, [...]
Aging Cells May Be Hiding From the Immune System – Scientists Think They Know How
Your immune system is supposed to clear out damaged cells. Researchers may have found how some of them hide and linger as the body ages. Researchers led by Cedars-Sinai Health Sciences University have identified [...]
Your Voice May Reveal How Fast Your Brain Is Aging
Researchers have developed a machine-learning “speech clock” that estimates age from subtle patterns in how people speak and what they say. It is possible that people’s voices may contain certain signals of aging that [...]
Optogenetics Pioneers Win 2026 Nobel Prize in Physiology or Medicine
The 2026 Nobel Prize in Physiology or Medicine has been awarded to Peter Hegemann, Georg Nagel, and Karl Deisseroth for the development of optogenetics, a revolutionary technology that uses light to control individual neurons [...]
Molecular Manufacturing: The Future of Nanomedicine – From NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
What is ‘American Covid’ and how bad is it?
Cases of so-called ‘American Covid’ are on the rise in the UK. The strain is officially called XFG, or ‘Stratus’, and is the most common variant in North America, hence the name. It might soon [...]
Researcher at Russian plague laboratory dies of ‘unknown’ infection
Russian authorities have imposed "anti-epidemic measures" after a laboratory worker at an institute in Siberia dedicated to studying the plague and other infectious diseases died of a mysterious illness. The researcher, a 28-year-old female [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
A Surprising Brain Signal Could Explain Why Eating Less Protein Extends Lifespan
A new paper suggests that limiting protein intake triggers a coordinated response throughout the body that may help explain how protein restriction affects healthy aging. Animals respond to protein restriction, or reduced protein in [...]
Back and shoulder surgery is often worse than useless
Millions of operations should be scrapped SIX IN TEN Britons have surgery at some point. So do lots of Americans, at a cost of perhaps $500bn a year, a third of all spending on [...]
Cocaine plays with mind, hijacks brain circuit, drives increasingly rigid and repetitive behavior
Researchers have found that cocaine hijacks brain circuit, which to drive increasingly rigid and repetitive behavior. The brain circuit that normally participates in selecting natural mouth and face movements, but which becomes disproportionately engaged [...]
Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma
The brain cancer glioblastoma is one of the most aggressive and treatment-resistant cancers known to medicine, carrying a median survival of just 12-15 months, even with the best available care. Now, researchers at the [...]
New Treatment Cuts “Bad” Cholesterol in Half for a Full Year
A single infusion of an experimental CRISPR-Cas9 therapy was reported to safely lower LDL cholesterol by 52.5% and triglycerides by 47.8%, as measured 12 months after treatment. What if one infusion could keep cholesterol [...]
Too Much RNA Can Drain a Cell’s Energy, Scientists Discover
A virus may cripple a cell’s power supply simply by producing too much of a molecule the cell needs to survive. New research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences [...]
